Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002381416 | SCV002688947 | likely benign | Cardiovascular phenotype | 2020-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002514569 | SCV003000806 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003155077 | SCV003844264 | likely benign | not specified | 2023-02-27 | criteria provided, single submitter | clinical testing | |
Willoughby Group, |
RCV000114792 | SCV000148687 | probable-pathogenic | Keratoconus 1 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |